Phase 2 Study of AG 013736 as Second-Line Treatment in Patients With Metastatic Renal Cell Cancer.
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2015
At a glance
- Drugs Axitinib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 24 Sep 2015 Results of effects of different degrees of renal impairment from one phase 3 and three phase 2 studies published in the Targeted Oncology.
- 09 Nov 2012 New source identified and integrated: German Clinical Trials Register record (Extension trial DRKS00004112).
- 19 Apr 2012 Actual patient number changed from 22 to 52 as reported by ClinicalTrials.gov (Extension trial: NCT01056263).